These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent. Kondo R; Feitelson MA; Strayer DS Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861 [TBL] [Abstract][Full Text] [Related]
7. In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer. Kimchi-Sarfaty C; Ben-Nun-Shaul O; Rund D; Oppenheim A; Gottesman MM Hum Gene Ther; 2002 Jan; 13(2):299-310. PubMed ID: 11812285 [TBL] [Abstract][Full Text] [Related]
8. A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants. Arad U; Ben-Nun-Shaul O; El-Latif MA; Nissim O; Oppenheim A Virology; 2002 Dec; 304(2):155-9. PubMed ID: 12504557 [TBL] [Abstract][Full Text] [Related]
9. Gene delivery to the liver using simian virus 40-derived vectors. Strayer DS; Zern MA Semin Liver Dis; 1999; 19(1):71-81. PubMed ID: 10349685 [TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways. Sumner-Jones SG; Davies LA; Varathalingam A; Gill DR; Hyde SC Gene Ther; 2006 Dec; 13(24):1703-13. PubMed ID: 16855618 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue. Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277 [TBL] [Abstract][Full Text] [Related]
15. Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction. Cotugno G; Annunziata P; Barone MV; Karali M; Banfi S; Auricchio A PLoS One; 2012; 7(3):e33286. PubMed ID: 22428010 [TBL] [Abstract][Full Text] [Related]
16. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Strayer DS; Kondo R; Milano J; Duan LX Gene Ther; 1997 Mar; 4(3):219-25. PubMed ID: 9135735 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors. Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369 [TBL] [Abstract][Full Text] [Related]
18. A packaging system for SV40 vectors without viral coding sequences. Fang B; Koch P; Bouvet M; Ji L; Roth JA Anal Biochem; 1997 Dec; 254(1):139-43. PubMed ID: 9398356 [TBL] [Abstract][Full Text] [Related]
19. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. Sauter BV; Parashar B; Chowdhury NR; Kadakol A; Ilan Y; Singh H; Milano J; Strayer DS; Chowdhury JR Gastroenterology; 2000 Nov; 119(5):1348-57. PubMed ID: 11054394 [TBL] [Abstract][Full Text] [Related]
20. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides. Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]